ZITHROMAX Safety Questions, ZITHROMAX Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about ZITHROMAX. Our extensive database of ZITHROMAX adverse events and ZITHROMAX warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about ZITHROMAX

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




ZITHROMAX Safety Reports

Total ZITHROMAX reports: 174.
ZITHROMAX FDA safety alerts: No.
Reported deaths: 7    Reported hospitalizations: 52.
Take ZITHROMAX Side Effects Survey or Share Your ZITHROMAX Story. ZITHROMAX Usage.

Showing 1-75 of 174 Next >

Pharmacist from GERMANY reported ZITHROMAX problem on July 18, 2006. Male patient, child 6 years of age, weighting 39.68 lb, was diagnosed with cough and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: alopecia, apathy. ZITHROMAX dosage: unknown. During the same period patient was treated with BRICANYL. Patient recovered.

ZITHROMAX problem was reported by a Physician from UNITED STATES on Aug 03, 2006. Male patient, 73 years of age, was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: chromaturia, hepatic trauma, ill-defined disorder, jaundice, liver disorder. ZITHROMAX dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZITHROMAX problem on July 22, 2006. Female patient, 56 years of age, weighting 417.0 lb, was diagnosed with pneumonia and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: anosmia, dysgeusia, feeling abnormal, hearing impaired, hypoaesthesia, panic attack. ZITHROMAX dosage: unknown. During the same period patient was treated with METFORMIN, ATENOLOL, HYDROCHLOROTHIAZIDE, ACCUPRIL, GLIPIZIDE, VITAMINS. Patient recovered.

ZITHROMAX problem was reported by a Pharmacist from GERMANY on July 24, 2006. Male patient, 15 years of age, was diagnosed with staphylococcal infection and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: extrapyramidal disorder, nervous system disorder. ZITHROMAX dosage: 250 MG, ORAL. During the same period patient was treated with LEVOFLOXACIN, TABALON, PULMICORT, OMEPRAZOLE, MAGNESIUM, DECORTIN. Patient recovered.

Health Professional from MALAYSIA reported ZITHROMAX problem on July 24, 2006. Male patient, 52 years of age, was diagnosed with pyrexia and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: hepatic failure, sepsis, stevens-johnson syndrome. ZITHROMAX dosage: unknown. During the same period patient was treated with CAPTOPRIL. Patient was hospitalized. Patient died.

ZITHROMAX problem was reported by a Physician from NETHERLANDS on July 25, 2006. Male patient, child 5 years of age, weighting 48.50 lb, was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: hypothermia. ZITHROMAX dosage: 240 MG (240 MG, 1 IN 1 D), ORAL. During the same period patient was treated with BROXIL, AMOXICILLIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZITHROMAX problem on Aug 01, 2006. Male patient, weighting 200.0 lb, was diagnosed with lyme disease, neuropathy, anxiety, depressed mood, ileostomy and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: anxiety, blood pressure increased, depressed level of consciousness, depressed mood, hallucination, headache, heart rate increased. ZITHROMAX dosage: unknown. During the same period patient was treated with NEURONTIN, LYRICA, ZOLOFT, BENADRYL, ROCEPHIN, HYOSCYAMINE, VALIUM. Patient recovered.

ZITHROMAX problem was reported by a Physician from JAPAN on Aug 03, 2006. Male patient, child 3 years of age, weighting 29.54 lb, was diagnosed with pyrexia and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: aspartate aminotransferase increased, bacterial infection, blood lactate dehydrogenase increased, bronchitis acute, cytokine storm, fibrin d dimer increased, fibrin degradation products increased, pyrexia, serum ferritin increased. ZITHROMAX dosage: unknown. During the same period patient was treated with ROCEPHIN, CLARITHROMYCIN. Patient was hospitalized. Patient recovered.

Health Professional from MALAYSIA reported ZITHROMAX problem on Aug 02, 2006. Male patient, 52 years of age, was diagnosed with pyrexia and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: hepatic failure, renal failure, sepsis, stevens-johnson syndrome. ZITHROMAX dosage: 500 MG (500 MG, 1 IN 1 D), ORAL. During the same period patient was treated with CEPOREX, CAPTOPRIL. Patient was hospitalized. Patient died on 07/19/2006.

ZITHROMAX problem was reported by a Pharmacist from UNITED STATES on Aug 16, 2006. Male patient, 84 years of age, weighting 130.1 lb, was diagnosed with bronchitis, pneumonia, convulsion and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: bronchitis, dyspnoea, gingival bleeding, pain, pneumonia, stevens-johnson syndrome, tremor, viral rash. ZITHROMAX dosage: 13 MLS 1ST DAY, THEN 6 MLS QD PO. During the same period patient was treated with LYRICA, VALPROATE, ZONEGRAN, ALBUTEROL, CLINDAMYCIN. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported ZITHROMAX problem on Aug 04, 2006. Female patient was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: injection site pain. ZITHROMAX dosage: unknown. Patient was hospitalized. Patient recovered.

ZITHROMAX problem was reported by a Consumer or non-health professional from GERMANY on Aug 14, 2006. Female patient, 32 years of age, was diagnosed with nasopharyngitis, tonsillitis and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: metrorrhagia. ZITHROMAX dosage: 500 MG, ORAL. During the same period patient was treated with MARCUMAR. Patient recovered.

Pharmacist from UNITED STATES reported ZITHROMAX problem on Aug 15, 2006. Female patient was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: phlebitis. ZITHROMAX dosage: 500 MG, INTRAVENOUS. Patient recovered.

ZITHROMAX problem was reported by a Pharmacist from UNITED STATES on Aug 15, 2006. Male patient, child 6 years of age, was diagnosed with cough and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, incorrect dose administered, overdose, respiratory depression. ZITHROMAX dosage: unknown. During the same period patient was treated with TUSSIONEX. Patient died on 04/11/2006.

Physician from UNITED STATES reported ZITHROMAX problem on Aug 15, 2006. Female patient, child 11 years of age, was diagnosed with cough and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: arrhythmia, cardiac hypertrophy, pericarditis, pulmonary congestion, pulmonary oedema, viral infection. ZITHROMAX dosage: unknown. During the same period patient was treated with TUSSIONEX. Patient died on 02/25/2006.

ZITHROMAX problem was reported by a Physician from UNITED STATES on Aug 19, 2006. Female patient, 80 years of age, weighting 100.0 lb, was diagnosed with tooth abscess and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: abasia, abdominal distension, abdominal pain, abdominal rigidity, faecal incontinence, flatulence, hyperaesthesia, weight decreased. ZITHROMAX dosage: 250 MG (250 MG, 1 IN 1 D), ORAL. During the same period patient was treated with VITAMIN, CALCIUM GLUCONATE, ENZYMES, LOPRESSOR, IMDUR, VITAMIN E, OPIUM TINCTURE, VITAMIN B. Patient recovered.

Physician from NETHERLANDS reported ZITHROMAX problem on Aug 21, 2006. Male patient, child 5 years of age, weighting 48.50 lb, was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: hypothermia. ZITHROMAX dosage: 240 MG (240 MG, 1 IN 1 D), ORAL. Patient recovered.

ZITHROMAX problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 22, 2006. Male patient, 58 years of age, weighting 163.0 lb, was diagnosed with lyme disease and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, blood glucose increased, disease recurrence, high density lipoprotein decreased, lyme disease, lymphocyte percentage decreased, mean cell haemoglobin concentration increased, pco2 decreased, pruritus. ZITHROMAX dosage: 500 MG (250 MG, 2 IN 1 D). During the same period patient was treated with REYATAZ, NORVIR, VIREAD, EPIVIR, ANDROGEL, ACYCLOVIR, LEVOTHYROXINE, FLONASE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZITHROMAX problem on Aug 21, 2006. Male patient, weighting 305.0 lb, was diagnosed with bronchitis and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: cardiac flutter, dry eye, eye inflammation, eye pruritus, palpitations, vision blurred. ZITHROMAX dosage: 500 MG (500 MG, 1 IN 1 D). Patient recovered.

ZITHROMAX problem was reported by a Pharmacist from UNITED KINGDOM on Aug 23, 2006. Female patient, 15 years of age, weighting 103.6 lb, was diagnosed with antibiotic prophylaxis and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: haemorrhage, hypoglycaemia, tremor. ZITHROMAX dosage: 500 MG (500 MG, 3 IN 1 WK), ORAL. During the same period patient was treated with COLOMYCIN, PULMOZYME, CREON, VITAMIN, VENTOLIN, SERETIDE. Patient recovered.

Physician from JAPAN reported ZITHROMAX problem on Aug 23, 2006. Female patient, 54 years of age, was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: hallucination, pharyngeal erythema, sleep paralysis. ZITHROMAX dosage: 500 MG, ORAL. During the same period patient was treated with BUFFERIN. Patient recovered.

ZITHROMAX problem was reported by a Pharmacist from UNITED KINGDOM on Aug 23, 2006. Female patient, 15 years of age, weighting 103.6 lb, was diagnosed with antibiotic prophylaxis and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia, tremor. ZITHROMAX dosage: 500 MG (500 MG, 3 IN 1 WK), ORAL. During the same period patient was treated with COLOMYCIN, PULMOZYME, CREON, VITAMIN, VENTOLIN, SERETIDE. Patient recovered.

Physician from GERMANY reported ZITHROMAX problem on Aug 28, 2006. Female patient, 16 years of age, was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: facial nerve disorder, paresis. ZITHROMAX dosage: unknown. Patient recovered.

ZITHROMAX problem was reported by a Physician from JAPAN on Sept 06, 2006. Male patient, child 3 years of age, weighting 29.54 lb, was diagnosed with pyrexia and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: aspartate aminotransferase increased, bacterial infection, blood lactate dehydrogenase increased, bronchitis acute, cytokine storm, fibrin degradation products increased, fibrin increased, serum ferritin increased. ZITHROMAX dosage: unknown. During the same period patient was treated with ROCEPHIN, CLARITHROMYCIN. Patient was hospitalized. Patient recovered.

Health Professional from JAPAN reported ZITHROMAX problem on Sept 04, 2006. Female patient, 14 years of age, was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: hyperventilation, oedema mouth, suicide attempt. ZITHROMAX dosage: 250 MG X 6 TAB., ORAL. Patient was hospitalized. Patient recovered.

ZITHROMAX problem was reported by a Pharmacist from UNITED STATES on Sept 18, 2006. Male patient, child 8 years of age, weighting 130.1 lb, was diagnosed with bronchitis, pneumonia, convulsion and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: pneumonia, stevens-johnson syndrome, tremor, viral rash. ZITHROMAX dosage: 13 MLS 1ST DAY, THEN 6 MLS QD ORAL. During the same period patient was treated with LYRICA, VALPROATE, ZONEGRAN, ALBUTEROL, CLINDAMYCIN. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported ZITHROMAX problem on Sept 21, 2006. Male patient, 82 years of age, weighting 200.0 lb, was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: swelling, wheezing. ZITHROMAX dosage: unknown. During the same period patient was treated with FORMOTEROL FUMARATE, MONTELUKAST NA, ALBUTEROL, IPRATROPIUM BROMIDE, METHYLPREDNISOLONE, FUROSEMIDE, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.

ZITHROMAX problem was reported by a Physician from JAPAN on Sept 07, 2006. Male patient, 28 years of age, weighting 143.3 lb, was diagnosed with urethritis trichomonal and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, alanine aminotransferase increased, aspartate aminotransferase increased, dyspnoea, food poisoning, gamma-glutamyltransferase increased, liver disorder, oral mucosal eruption, pyrexia. ZITHROMAX dosage: 1000 MG (1000 MG, ONCE), ORAL. Patient was hospitalized. Patient recovered.

Pharmacist from GERMANY reported ZITHROMAX problem on Sept 07, 2006. Male patient, 15 years of age, was diagnosed with staphylococcal infection and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: extrapyramidal disorder, nervous system disorder. ZITHROMAX dosage: 250 MG, ORAL; LONG-TERM. During the same period patient was treated with LEVOFLOXACIN, TABALON, PULMICORT, OMEPRAZOLE, MAGNESIUM, DECORTIN. Patient recovered.

ZITHROMAX problem was reported by a Health Professional from IRELAND on Sept 07, 2006. Female patient, 37 years of age, was diagnosed with obliterative bronchiolitis and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: hypocalcaemia, myalgia, paraesthesia. ZITHROMAX dosage: 250 MG (250 MG). During the same period patient was treated with CLARITHROMYCIN, MONTELUKAST, DEXAMETHASONE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZITHROMAX problem on Sept 12, 2006. Male patient, 58 years of age, weighting 163.0 lb, was diagnosed with lyme disease and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, disease recurrence, lyme disease, pruritus. ZITHROMAX dosage: 500 MG (250 MG, 2 IN 1 D). During the same period patient was treated with REYATAZ, NORVIR, VIREAD, EPIVIR, ANDROGEL, ACYCLOVIR, LEVOTHYROXINE, FLONASE. Patient recovered.

ZITHROMAX problem was reported by a Physician from UNITED KINGDOM on Sept 13, 2006. Male patient was diagnosed with upper respiratory tract infection, atrial fibrillation and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: haemorrhage, impaired work ability, vocal cord disorder. ZITHROMAX dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE, WARFARIN. Patient recovered.

Physician from JAPAN reported ZITHROMAX problem on Sept 13, 2006. Female patient, 64 years of age, was diagnosed with bronchitis and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: colitis ischaemic, diarrhoea, melaena, vomiting. ZITHROMAX dosage: 500 MG, ORAL. During the same period patient was treated with TARIVID, HOKUNALIN, MUCOSOLVAN. Patient was hospitalized. Patient recovered.

ZITHROMAX problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 14, 2006. Female patient, 75 years of age, weighting 119.0 lb, was diagnosed with bronchitis and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: diarrhoea, rectal haemorrhage. ZITHROMAX dosage: 250 MG. Patient recovered.

Physician from UNITED STATES reported ZITHROMAX problem on Sept 18, 2006. Female patient, 46 years of age, was diagnosed with nasopharyngitis, sinus congestion and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: ageusia, anosmia, diarrhoea, hypoacusis, myalgia, oral intake reduced, vision blurred, weight decreased. ZITHROMAX dosage: 500 MG (500 MG, DAILY), ORAL. During the same period patient was treated with ZYRTEC, PLE VITAMINS. Patient recovered.

ZITHROMAX problem was reported by a Physician from JAPAN on Sept 15, 2006. Female patient, weighting 31.97 lb, was diagnosed with upper respiratory tract inflammation and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: bedridden, body temperature increased, hypothermia. ZITHROMAX dosage: 150 MG (150 MG, 1 IN 1 D), ORAL. During the same period patient was treated with BIOFERMIN R, IBUPROFEN. Patient recovered.

Pharmacist from UNITED STATES reported ZITHROMAX problem on Oct 02, 2006. Male patient, 75 years of age, was diagnosed with infection and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: dizziness, feeling abnormal, orthostatic hypotension. ZITHROMAX dosage: 500 MG QD PO. Patient was hospitalized. Patient recovered.

ZITHROMAX problem was reported by a Consumer or non-health professional from GREECE on Sept 20, 2006. Male patient was diagnosed with pyrexia and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: bone pain, delirium, myalgia, tongue discolouration. ZITHROMAX dosage: 500 MG (500 MG), ORAL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZITHROMAX problem on Oct 05, 2006. Female patient, weighting 185.0 lb, was diagnosed with influenza and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: oedema peripheral, onychomadesis, scar, skin exfoliation. ZITHROMAX dosage: unknown. Patient recovered.

ZITHROMAX problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 06, 2006. Female patient, 37 years of age, weighting 238.0 lb, was diagnosed with upper respiratory tract infection and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. ZITHROMAX dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZITHROMAX problem on Sept 25, 2006. Male patient, 49 years of age, weighting 208.0 lb, was diagnosed with influenza and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, endocarditis bacterial, malaise, oedema peripheral, pain, skin disorder, skin lesion, syncope. ZITHROMAX dosage: 500 MG (500 MG, 1 IN 1 D). During the same period patient was treated with GLUCOPHAGE. Patient was hospitalized. Patient recovered.

ZITHROMAX problem was reported by a Physician from MOROCCO on Sept 29, 2006. Female patient, 28 years of age, was diagnosed with tonsillitis and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, shock, vomiting. ZITHROMAX dosage: 500 MG (500 MG, 1 IN 1 D), ORAL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZITHROMAX problem on Sept 29, 2006. Female patient, 61 years of age, was diagnosed with hepatitis c and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: anxiety, asthma, chills, condition aggravated, depression, gingival bleeding, insomnia, rectal haemorrhage. ZITHROMAX dosage: unknown. During the same period patient was treated with RIBAVIRIN, ISOSORBIDE MONONITRATE, LIPITOR, LISINOPRIL, NORTRIPTYLINE, VITAMIN B12, PLAVIX. Patient recovered.

ZITHROMAX problem was reported by a Physician from FRANCE on Oct 02, 2006. Female patient, 16 years of age, weighting 99.21 lb, was diagnosed with herpes ophthalmic and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, balance disorder, confusional state, diarrhoea, extrapyramidal disorder, hallucination, headache, hearing impaired, musculoskeletal stiffness. ZITHROMAX dosage: 500 MG (250 MG, INTERVAL: EVERY DAY). During the same period patient was treated with BETAMETHASONE, METOPIMAZINE, CLINDAMYCIN HYDROCHLORIDE, PYRIMETHAMINE, ACIDE FOLIQUE, POTASSIUM CHLORURE, VALACICLOVIR CHLORHYDRATE. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported ZITHROMAX problem on Oct 23, 2006. Female patient, 58 years of age, weighting 82.00 lb, was diagnosed with pneumonia and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: injection site erythema, rash macular. ZITHROMAX dosage: 500MG IV X 1. Patient recovered.

ZITHROMAX problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 11, 2006. Female patient, 38 years of age, weighting 220.0 lb, was diagnosed with pharyngolaryngeal pain and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: burning sensation, diarrhoea, erythema, feeling hot, nausea, pruritus, rash, skin ulcer, vomiting. ZITHROMAX dosage: unknown. Patient recovered.

Pharmacist from UNITED STATES reported ZITHROMAX problem on Oct 26, 2006. Male patient, 45 years of age, weighting 110.0 lb, was diagnosed with mycobacterium avium complex infection, groin abscess and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: clostridium difficile colitis, vomiting. ZITHROMAX dosage: unknown. During the same period patient was treated with BACTRIM DS. Patient was hospitalized. Patient recovered.

ZITHROMAX problem was reported by a Physician from GERMANY on Oct 12, 2006. Male patient, 31 years of age, weighting 185.2 lb, was diagnosed with bronchitis and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: lipase increased. ZITHROMAX dosage: 500 MG (250 MG,2 IN 1 D), ORAL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZITHROMAX problem on Oct 13, 2006. Female patient, 57 years of age, was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: psychotic disorder. ZITHROMAX dosage: unknown. During the same period patient was treated with CYMBALTA. Patient was hospitalized. Patient recovered.

ZITHROMAX problem was reported by a Physician from MOROCCO on Oct 17, 2006. Female patient, 28 years of age, was diagnosed with tonsillitis and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, shock, vomiting. ZITHROMAX dosage: 500 MG (500 MG, 1 IN 1 D), ORAL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZITHROMAX problem on Oct 18, 2006. Male patient, 80 years of age, weighting 145.0 lb, was diagnosed with bronchial disorder and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: body temperature increased, incorrect dose administered, nasal congestion, pollakiuria, treatment noncompliance, unevaluable event. ZITHROMAX dosage: 500 MG (250 MG, 2 IN 1 D), ORAL. Patient recovered.

ZITHROMAX problem was reported by a Consumer or non-health professional from UNITED STATES on May 10, 2005. Female patient, weighting 138.0 lb, was diagnosed with respiratory tract infection and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: arthritis, cardiac valve disease, condition aggravated, hypertrophic osteoarthropathy, post-traumatic stress disorder, pyrexia, tricuspid valve incompetence. ZITHROMAX dosage: 250 MG (250 MG, DAILY), ORAL. During the same period patient was treated with ADVAIR DISKUS, SPIRIVA, ALBUTEROL, NEXIUM, HYDROMORPHONE, AVANZA, ZANAFLEX, ZOFRAN. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported ZITHROMAX problem on Oct 23, 2006. Male patient, 49 years of age, weighting 208.0 lb, was diagnosed with influenza like illness and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, chills, endocarditis bacterial, oedema peripheral, pain, skin lesion, syncope. ZITHROMAX dosage: 500 MG (500 MG, 1 IN 1 D), ORAL. During the same period patient was treated with GLUCOPHAGE, GLYBURIDE. Patient was hospitalized. Patient recovered.

ZITHROMAX problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 23, 2006. Male patient, 27 years of age, was diagnosed with sinusitis and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: chest discomfort, myocardial infarction. ZITHROMAX dosage: 500 MG (500 MG, 1 IN 1 D), ORAL. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported ZITHROMAX problem on Oct 17, 2006. Male patient, 63 years of age, weighting 189.6 lb, was diagnosed with nasopharyngitis and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: anosmia, dysgeusia, parosmia. ZITHROMAX dosage: 500 MG (500 MG), ORAL. During the same period patient was treated with PARACODIN. Patient recovered.

ZITHROMAX problem was reported by a Physician from MOROCCO on Oct 31, 2006. Female patient, 28 years of age, was diagnosed with tonsillitis and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, shock, vomiting. ZITHROMAX dosage: 500 MG (500 MG, FREQUENCY: ONCE INTERVAL: DAY), ORAL. Patient recovered.

Physician from GERMANY reported ZITHROMAX problem on Nov 07, 2006. Female patient, 13 years of age, weighting 127.9 lb, was diagnosed with tonsillitis and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: onychalgia, paraesthesia. ZITHROMAX dosage: 500 MG (250 MG, 2 IN 1 D), ORAL. Patient was hospitalized. Patient recovered.

ZITHROMAX problem was reported by a Physician from JAPAN on Nov 09, 2006. Male patient, weighting 22.05 lb, was diagnosed with pyrexia and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, haematochezia, haemolytic anaemia, pyrexia, upper respiratory tract inflammation. ZITHROMAX dosage: 100 MG (100 MG, 1 IN 1 D), ORAL. During the same period patient was treated with ANHIBA, CEFDINIR. Patient was hospitalized. Patient recovered.

Physician from NETHERLANDS reported ZITHROMAX problem on Nov 14, 2006. Male patient, 52 years of age, was diagnosed with respiratory tract infection and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: myocardial infarction. ZITHROMAX dosage: 500 MG (500 MG, 1 IN 1 D), ORAL. During the same period patient was treated with DEPAKENE, LORMETAZEPAM, NEORAL. Patient was hospitalized. Patient recovered.

ZITHROMAX problem was reported by a Consumer or non-health professional from FRANCE on Nov 13, 2006. Female patient, 36 years of age, was diagnosed with pharyngolaryngeal pain and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: ear pain, migraine, nausea, tinnitus, vertigo. ZITHROMAX dosage: 250 MG (250 MG, 1 IN 1 D), ORAL. Patient recovered.

Pharmacist from CANADA reported ZITHROMAX problem on Nov 21, 2006. Female patient, 45 years of age, was diagnosed with pneumonia and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: ageusia, anosmia, dysgeusia. ZITHROMAX dosage: unknown. Patient recovered.

ZITHROMAX problem was reported by a Physician from CHINA on Nov 23, 2006. Male patient, 53 years of age, was diagnosed with upper respiratory tract infection and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: vasculitis. ZITHROMAX dosage: 500 MG (500 MG, 1 IN 1 D), INTRAVENOUS. Patient recovered.

Physician from UNITED STATES reported ZITHROMAX problem on Nov 20, 2006. Male patient, 78 years of age, weighting 170.0 lb, was diagnosed with sinusitis, iron overload and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: acute prerenal failure, blood creatinine increased, blood urea increased, decreased appetite, dehydration, diarrhoea, fatigue, nausea. ZITHROMAX dosage: unknown. During the same period patient was treated with EXJADE. Patient recovered.

ZITHROMAX problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 12, 2006. Male patient, 68 years of age, weighting 178.0 lb, was diagnosed with pneumonia and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: anosmia. ZITHROMAX dosage: unknown. Patient recovered.

Physician from GREECE reported ZITHROMAX problem on Nov 28, 2006. Female patient, 52 years of age, was diagnosed with pneumonia and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: hallucinations, mixed. ZITHROMAX dosage: unknown. During the same period patient was treated with PIPERACILLIN AND TAZOBACTAM, CIPROFLOXACIN. Patient recovered.

ZITHROMAX problem was reported by a Health Professional from UNITED STATES on Nov 25, 2006. Female patient, 57 years of age, was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: anxiety, dystonia, hyperventilation, hypokalaemia, infection, oculogyration. ZITHROMAX dosage: unknown. During the same period patient was treated with EVISTA, POTASSIUM, ZOCOR, HYDROCHLOROTHIAZIDE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZITHROMAX problem on Dec 04, 2006. Female patient, 80 years of age, weighting 145.0 lb, was diagnosed with bronchial disorder and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: body temperature increased, incorrect dose administered, nasal congestion, pollakiuria, treatment noncompliance. ZITHROMAX dosage: 500 MG (250 MG, 2 IN 1 D), ORAL. Patient recovered.

ZITHROMAX problem was reported by a Physician from CANADA on Dec 05, 2006. Male patient, 15 years of age, was diagnosed with pharyngolaryngeal pain and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: convulsion, hallucination. ZITHROMAX dosage: unknown. Patient recovered.

Physician from CANADA reported ZITHROMAX problem on Dec 05, 2006. Male patient, child 4 years of age, was diagnosed with pharyngolaryngeal pain and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: convulsion, hallucination. ZITHROMAX dosage: unknown. Patient recovered.

ZITHROMAX problem was reported by a Health Professional from FRANCE on Dec 04, 2006. Male patient, 27 years of age, weighting 169.8 lb, was diagnosed with pharyngitis and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: nephritis interstitial, renal failure. ZITHROMAX dosage: unknown. During the same period patient was treated with ADVIL. Patient was hospitalized. Patient recovered.

Pharmacist from CANADA reported ZITHROMAX problem on Dec 05, 2006. Female patient, 45 years of age, weighting 153.0 lb, was diagnosed with pneumonia and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: ageusia, anosmia. ZITHROMAX dosage: unknown. During the same period patient was treated with LEVOTHYROXINE, RANITIDINE. Patient recovered.

ZITHROMAX problem was reported by a Physician from UNITED STATES on Nov 20, 2006. Male patient, 78 years of age, weighting 170.0 lb, was diagnosed with sinusitis, iron overload and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: acute prerenal failure, blood creatinine increased, blood urea increased, decreased appetite, dehydration, diarrhoea, fatigue, nausea. ZITHROMAX dosage: unknown. During the same period patient was treated with EXJADE. Patient recovered.

Physician from UNITED STATES reported ZITHROMAX problem on Dec 11, 2006. Male patient, 49 years of age, weighting 208.0 lb, was diagnosed with influenza like illness and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, endocarditis staphylococcal, oedema peripheral, pain, skin depigmentation, skin lesion, syncope. ZITHROMAX dosage: 500 MG (500 MG, 1 IN 1 D), ORAL. During the same period patient was treated with GLUCOPHAGE, GLYBURIDE. Patient was hospitalized. Patient recovered.

ZITHROMAX problem was reported by a Physician from SPAIN on May 04, 2006. Female patient, weighting 116.8 lb, was diagnosed with influenza and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: bronchospasm, mental disorder, pneumonia, pyrexia, stress, tremor. ZITHROMAX dosage: unknown. During the same period patient was treated with TIRODRIL, XALATAN, TRAMAZOLINE. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported ZITHROMAX problem on Dec 26, 2006. Female patient, 37 years of age, weighting 170.0 lb, was diagnosed with sinusitis and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: abdominal pain, diarrhoea haemorrhagic. ZITHROMAX dosage: 500 MG ONCE PO. Patient recovered.

Showing 1-75 of 174 Next >

Ask Our Patient Community about ZITHROMAX

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol